0

Dyslipidemia Collection
 1-20 of 57 Articles
ACP Journal Club |  20 September 2016
Review: Omega-3 HUFAs added to antidepressant therapy may reduce depression symptoms
Gregory Simon, MD, MPH
Ann Intern Med. 2016;165(6):JC28. doi:10.7326/ACPJC-2016-165-6-028
ACP Journal Club |  20 September 2016
Review: In patients with depressive disorders, EPA-predominant omega-3 HUFAs improve depression symptoms
Gregory Simon, MD, MPH
Ann Intern Med. 2016;165(6):JC29. doi:10.7326/ACPJC-2016-165-6-029
ACP Journal Club |  19 July 2016
Rosuvastatin reduced major cardiovascular events in patients at intermediate cardiovascular risk
Charles B. Eaton MD, MS
Ann Intern Med. 2016;165(2):JC6. doi:10.7326/ACPJC-2016-165-2-006
ACP Journal Club |  19 July 2016
Adding candesartan-HCTZ to rosuvastatin increased adverse events but not benefits in patients at intermediate CV risk
Charles B. Eaton MD, MS
Ann Intern Med. 2016;165(2):JC8. doi:10.7326/ACPJC-2016-165-2-008
ACP Journal Club |  19 April 2016
Review: In older persons at vascular risk, statins do not prevent dementia or cognitive decline at 3.5 to 5 years
Eric B. Larson, MD, MPH
Ann Intern Med. 2016;164(8):JC42. doi:10.7326/ACPJC-2016-164-8-042
ACP Journal Club |  15 March 2016
Review: PCSK9 inhibitors reduce mortality but increase neurocognitive events in hypercholesterolemia
Raul D. Santos, MD, PhD
Ann Intern Med. 2016;164(6):JC31. doi:10.7326/ACPJC-2016-164-6-031
ACP Journal Club |  19 January 2016
Lifestyle-focused text messages reduced LDL-C levels, systolic BP, and BMI in coronary heart disease
Hanna E. Bloomfield, MD, MPH
Ann Intern Med. 2016;164(2):JC7. doi:10.7326/ACPJC-2016-164-2-007
ACP Journal Club |  17 November 2015
ACC/AHA guidelines determining statin eligibility better predicted CVD than ATP-III guidelines
Raul D. Santos, MD, PhD, MSc
Ann Intern Med. 2015;163(10):JC11. doi:10.7326/ACPJC-2015-163-10-011
ACP Journal Club |  15 September 2015
Adding ezetimibe to simvastatin improved cardiovascular outcomes in stable acute coronary syndrome
Christopher B. Fordyce, MD, MSc; Christopher B. Granger, MD
Ann Intern Med. 2015;163(6):JC7. doi:10.7326/ACPJC-2015-163-6-007
ACP Journal Club |  18 August 2015
In palliative care, discontinuation of statins did not differ from continuation for mortality
Martin Stockler, MD
Ann Intern Med. 2015;163(4):JC7. doi:10.7326/ACPJC-2015-163-4-007
ACP Journal Club |  19 May 2015
Review: Statins do not increase adverse cognitive effects in patients with or without initial cognitive impairment
Steven M. Belknap, MD, FACP, FCP
Ann Intern Med. 2015;162(10):JC6. doi:10.7326/ACPJC-2015-162-10-006
ACP Journal Club |  17 February 2015
Review: Periprocedural high-dose statins reduce contrast-induced acute kidney injury after coronary angiography
Richard G. Bach, MD
Ann Intern Med. 2015;162(4):JC4. doi:10.7326/ACPJC-2015-162-4-004
ACP Journal Club |  16 December 2014
Review: In adult outpatients, nurse-managed protocols improve hemoglobin A1c levels and blood pressure
Kevin A. Schulman, MD
Ann Intern Med. 2014;161(12):JC6. doi:10.7326/0003-4819-161-12-201412160-02006
ACP Journal Club |  18 November 2014
Review: Statins before coronary catheterization reduce contrast-induced acute kidney injury
Himanshu Aggarwal, MD, MPH; Brigitta C. Brott, MD
Ann Intern Med. 2014;161(10):JC7. doi:10.7326/0003-4819-161-10-201411180-02007
ACP Journal Club |  18 November 2014
Adding niacin plus laropiprant to statins did not reduce vascular events and increased serious adverse events
Hanna E. Bloomfield, MD, MPH
Ann Intern Med. 2014;161(10):JC8. doi:10.7326/0003-4819-161-10-201411180-02008
ACP Journal Club |  21 October 2014
Pooled RCTs: Atorvastatin did not increase renal-related serious adverse events
William Herrington, MD; Richard Haynes, MD
Ann Intern Med. 2014;161(8):JC8. doi:10.7326/0003-4819-161-8-201410210-02008
ACP Journal Club |  19 August 2014
ACC/AHA Pooled Cohort Risk Equations predicted 5-y risk for CV events in adults considered for statin initiation
Ann Marie Navar-Boggan, MD, PhD; L. Kristin Newby, MD, MHS
Ann Intern Med. 2014;161(4):JC12. doi:10.7326/0003-4819-161-4-201408190-02012
ACP Journal Club |  15 July 2014
Review: Statins do not increase minor or serious symptomatic adverse events in placebo-controlled trials
Meera Jain, MD; Richard Wernick, MD
Ann Intern Med. 2014;161(2):JC3. doi:10.7326/0003-4819-161-2-201407150-02003
ACP Journal Club |  20 May 2014
Review: In older patients without CVD, statins reduce MI and stroke but not all-cause mortality
Saul Schaefer, MD
Ann Intern Med. 2014;160(10):JC8. doi:10.7326/0003-4819-160-10-201405200-02008
ACP Journal Club |  20 May 2014
Early high-dose rosuvastatin prevented contrast-induced acute kidney injury in non–ST-elevation ACS
Amber O. Molnar, MD; Amit X. Garg, MD
Ann Intern Med. 2014;160(10):JC9. doi:10.7326/0003-4819-160-10-201405200-02009
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)